MLX Antibody (internal region)
Peptide-affinity purified goat antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| IHC, E |
---|---|
Primary Accession | Q9UH92 |
Other Accession | NP_937848.1, NP_937847.1, NP_733752.1, 6945, 21428 (mouse), 360631 (rat) |
Reactivity | Human |
Predicted | Mouse, Rat, Dog, Cow |
Host | Goat |
Clonality | Polyclonal |
Concentration | 0.5 mg/ml |
Isotype | IgG |
Other Names | Max-like protein X, Class D basic helix-loop-helix protein 13, bHLHd13, Max-like bHLHZip protein, Protein BigMax, Transcription factor-like protein 4, MLX, BHLHD13, TCFL4 |
---|---|
Format | 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | MLX Antibody (internal region) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | MLX |
---|---|
Synonyms | BHLHD13, TCFL4 |
Function | Transcription regulator. Forms a sequence-specific DNA- binding protein complex with MAD1, MAD4, MNT, WBSCR14 and MLXIP which recognizes the core sequence 5'-CACGTG-3'. The TCFL4-MAD1, TCFL4-MAD4, TCFL4-WBSCR14 complexes are transcriptional repressors. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation. |
Cellular Location | Isoform Alpha: Cytoplasm. Note=Found predominantly in the cytoplasm (PubMed:10918583). Isoform Gamma: Nucleus. Note=Found predominantly in the nucleus (PubMed:10918583). |
Tissue Location | Expressed in all tissues tested, including spleen, thymus, prostate, ovary, intestine, colon, peripheral blood leukocyte, heart, liver, skeletal muscle and kidney. Lower levels of expression in testis, brain, placenta and lung EMBL; AF203978; AAF14638.1; -; mRNA EMBL; AF213666; AAG40145.1; -; mRNA EMBL; AF213667; AAG40146.1; -; mRNA EMBL; AF213668; AAG40147.1; -; mRNA EMBL; AK000150; BAA90977.1; -; mRNA EMBL; AK290258; BAF82947.1; -; mRNA EMBL; AK314378; BAG37005.1; -; mRNA EMBL; AK315432; BAG37820.1; -; mRNA EMBL; BT009812; AAP88814.1; -; mRNA EMBL; BC010689; AAH10689.1; -; mRNA CCDS; CCDS11430.1; -. [Q9UH92-1] CCDS; CCDS42341.1; -. [Q9UH92-2] CCDS; CCDS45687.1; -. [Q9UH92-3] PIR; JC5333; JC5333 RefSeq; NP_733752.1; NM_170607.2. [Q9UH92-1] RefSeq; NP_937847.1; NM_198204.1. [Q9UH92-3] RefSeq; NP_937848.1; NM_198205.1. [Q9UH92-2] UniGene; Hs.383019; - UniGene; Hs.714749; - ProteinModelPortal; Q9UH92; - SMR; Q9UH92; - BioGrid; 112805; 27 IntAct; Q9UH92; 31 MINT; Q9UH92; - STRING; 9606.ENSP00000246912; - BindingDB; Q9UH92; - ChEMBL; CHEMBL2062357; - iPTMnet; Q9UH92; - PhosphoSitePlus; Q9UH92; - BioMuta; MLX; - DMDM; 20138856; - EPD; Q9UH92; - PaxDb; Q9UH92; - PeptideAtlas; Q9UH92; - PRIDE; Q9UH92; - ProteomicsDB; 84286; - ProteomicsDB; 84287; -. [Q9UH92-2] ProteomicsDB; 84288; -. [Q9UH92-3] DNASU; 6945; - Ensembl; ENST00000246912; ENSP00000246912; ENSG00000108788. [Q9UH92-1] Ensembl; ENST00000346833; ENSP00000320913; ENSG00000108788. [Q9UH92-2] Ensembl; ENST00000435881; ENSP00000416627; ENSG00000108788. [Q9UH92-3] GeneID; 6945; - KEGG; hsa:6945; - UCSC; uc002iaf.4; human. [Q9UH92-1] CTD; 6945; - DisGeNET; 6945; - EuPathDB; HostDB:ENSG00000108788.11; - GeneCards; MLX; - HGNC; HGNC:11645; MLX HPA; CAB025329; - HPA; HPA052766; - HPA; HPA064438; - MalaCards; MLX; - MIM; 602976; gene neXtProt; NX_Q9UH92; - OpenTargets; ENSG00000108788; - Orphanet; 3287; Takayasu arteritis PharmGKB; PA36397; - eggNOG; KOG1319; Eukaryota eggNOG; ENOG410ZWIP; LUCA GeneTree; ENSGT00530000063219; - HOVERGEN; HBG019061; - InParanoid; Q9UH92; - KO; K09113; - OMA; IMEEMFE; - OrthoDB; EOG091G0RUK; - PhylomeDB; Q9UH92; - TreeFam; TF318841; - Reactome; R-HSA-163765; ChREBP activates metabolic gene expression ChiTaRS; MLX; human GeneWiki; MLX_(gene); - GenomeRNAi; 6945; - PRO; PR:Q9UH92; - Proteomes; UP000005640; Chromosome 17 Bgee; ENSG00000108788; - CleanEx; HS_MLX; - ExpressionAtlas; Q9UH92; baseline and differential Genevisible; Q9UH92; HS GO; GO:0005737; C:cytoplasm; IDA:UniProtKB GO; GO:0005829; C:cytosol; IDA:HPA GO; GO:0031965; C:nuclear membrane; IDA:HPA GO; GO:0005654; C:nucleoplasm; IDA:HPA GO; GO:0005634; C:nucleus; IDA:UniProtKB GO; GO:0003677; F:DNA binding; IDA:BHF-UCL GO; GO:0003700; F:DNA binding transcription factor activity; NAS:UniProtKB GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:NTNU_SB GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:NTNU_SB GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW CDD; cd00083; HLH; 1 Gene3D; 4.10.280.10; -; 1 InterPro; IPR011598; bHLH_dom InterPro; IPR036638; HLH_DNA-bd_sf InterPro; IPR032647; Mlx PANTHER; PTHR15741:SF25; PTHR15741:SF25; 1 Pfam; PF00010; HLH; 1 SMART; SM00353; HLH; 1 SUPFAM; SSF47459; SSF47459; 1 PROSITE; PS50888; BHLH; 1 1: Evidence at protein level; Activator; Alternative splicing; Complete proteome; Cytoplasm; DNA-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repressor; Transcription; Transcription regulation CHAIN 1 298 Max-like protein X /FTId=PRO_0000127279 DOMAIN 129 187 bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981} REGION 140 160 Leucine-zipper MOD_RES 7 7 Phosphoserine MOD_RES 45 45 Phosphoserine {ECO:0000250|UniProtKB:O08609} MOD_RES 48 48 Phosphoserine {ECO:0000250|UniProtKB:O08609} MOD_RES 74 74 Phosphoserine MOD_RES 77 77 Phosphoserine MOD_RES 98 98 Phosphoserine VAR_SEQ 15 68 Missing (in isoform Alpha and isoform Beta). {ECO:0000303|PubMed:10593926, ECO:0000303|PubMed:10918583, ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4} /FTId=VSP_002137 VAR_SEQ 81 110 Missing (in isoform Alpha) /FTId=VSP_002138 VARIANT 223 223 Q -> R (in dbSNP:rs665268) /FTId=VAR_049547 CONFLICT 247 247 D -> V (in Ref. 1; AAF14638) CONFLICT 298 298 Y -> C (in Ref. 3; BAA90977) SEQUENCE 298 AA; 33300 MW; D1981730051473C5 CRC64; MTEPGASPED PWVKASPVGA HAGEGRAGRA RARRGAGRRG ASLLSPKSPT LSVPRGCRED SSHPACAKVE YAYSDNSLDP GLFVESTRKG SVVSRANSIG STSASSVPNT DDEDSDYHQE AYKESYKDRR RRAHTQAEQK RRDAIKRGYD DLQTIVPTCQ QQDFSIGSQK LSKAIVLQKT IDYIQFLHKE KKKQEEEVST LRKDVTALKI MKVNYEQIVK AHQDNPHEGE DQVSDQVKFN VFQGIMDSLF QSFNASISVA SFQELSACVF SWIEEHCKPQ TLREIVIGVL HQLKNQLY |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abgent.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This antibody is expected to recognize all three reported isoforms (NP_937848.1; NP_937847.1; NP_733752.1).
References
Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Stoltzman CA, Peterson CW, Breen KT, Muoio DM, Billin AN, Ayer DE, Proceedings of the National Academy of Sciences of the United States of America 2008 May 105 (19): 6912-7. PMID: 18458340

If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.